Hu Lei

Dr. Hu Lei


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2012 in Immunity
Verified
Journal Article
Closed access
YLYuping Lai
Yuping Lai
DLDongqing Li
Dongqing Li
CLChangwei Li
Changwei Li
BMBeda Muehleisen
Beda Muehleisen
KRKatherine A. Radek
Katherine A. Radek
RGRichard L. Gallo
Richard L. Gallo

10 November 2016 in Nature Communications
Verified
Journal Article
Open access
YWYelin Wu
Yelin Wu
YQYanchun Quan
Yanchun Quan
YLYuanqi Liu
Yuanqi Liu
KLKeiwei Liu
Keiwei Liu
HLHongquan Li
Hongquan Li
YLYuping Lai
Yuping Lai
Dysregulated inflammatory responses are known to impair wound healing in diabetes, but the underlying mechanisms are poorly understood. Here we show that the antimicrobial protein REG3A controls TLR3-mediated inflammation after skin injury. This control is mediated by REG3A-induced SHP-1 protein, and acts selectively on TLR3-activated JNK2. In diabetic mouse skin, hyperglycaemia inhibits the expression of IL-17-induced IL-33 via glucose glycation. The decrease in cutaneous IL-33 reduces REG3A expression in epidermal keratinocytes. The reduction in REG3A is associated with lower levels of SHP-1, which normally inhibits TLR3-induced JNK2 phosphorylation, thereby increasing inflammation in skin wounds. To our knowledge, these findings show for the first time that REG3A can modulate specific cutaneous inflammatory responses and that the decrease in cutaneous REG3A exacerbates inflammation in diabetic skin wounds.

5 March 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DLDongqing Li
Dongqing Li
HLHu Lei
Hu Lei
ZLZhiheng Li
Zhiheng Li
HLHongquan Li
Hongquan Li
YWYue Wang
Yue Wang
YLYuping Lai
Yuping Lai
Staphylococcus epidermidis (S.epidermidis) plays important protective roles by directly producing or by stimulating hosts to produce antimicrobial peptides (AMPs) against pathogenic infections. Although several AMPs from S.epidermidis have been identified, molecules that stimulate hosts to produce AMPs remain largly unknown. Here we demonstrate that a new lipopeptide (named LP01) purified from S.epidermidis culture media has a unique structure with heneicosanoic acid (21 carbons) binding to lysine11 of a peptide chain. In vitro LP01 increased the expression of β-defensin 2(hBD2) and hBD3 in neonatal human epidermal keratinocytes(NHEK), leading to increased capacity of cell lysates to inhibit the growth of S.aureus. In vivo LP01 induced the expression of mouse β-defensin 4(mBD4) to decrease the survival of local S.aureus in skin and systemic S.aureus survival in liver. The induction of beta-defensins by LP01 was dependent on TLR2 as Tlr2-deficient mice had decreased mBD4. Furthermore, knockdown of CD36 decreased the expression of hBD2 and hBD3, and p38 MAPK inhibitor significantly inhibited the expression of hBDs induced by LP01.Taken together, these findings demonstrate that lipopeptide LP01 from normal commensal S.epidermidis increases antimicrobial peptide hBD2 and hBD3 expression via the activation of TLR2/CD36-p38 MAPK, thus enhancing antimicrobial defense against pathogenic infections.

4 January 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
HLHu Lei
Hu Lei
HXHan-Zhang Xu
Han-Zhang Xu
HSHui-Zhuang Shan
Hui-Zhuang Shan
MLMeng Liu
Meng Liu
YLYing Lu
Ying Lu
YWYINGLI WU
YINGLI WU
Identifying novel drug targets to overcome resistance to tyrosine kinase inhibitors (TKIs) and eradicating leukemia stem/progenitor cells are required for the treatment of chronic myelogenous leukemia (CML). Here, we show that ubiquitin-specific peptidase 47 (USP47) is a potential target to overcome TKI resistance. Functional analysis shows that USP47 knockdown represses proliferation of CML cells sensitive or resistant to imatinib in vitro and in vivo. The knockout of Usp47 significantly inhibits BCR-ABL and BCR-ABLT315I-induced CML in mice with the reduction of Lin−Sca1+c-Kit+ CML stem/progenitor cells. Mechanistic studies show that stabilizing Y-box binding protein 1 contributes to USP47-mediated DNA damage repair in CML cells. Inhibiting USP47 by P22077 exerts cytotoxicity to CML cells with or without TKI resistance in vitro and in vivo. Moreover, P22077 eliminates leukemia stem/progenitor cells in CML mice. Together, targeting USP47 is a promising strategy to overcome TKI resistance and eradicate leukemia stem/progenitor cells in CML.

16 July 2016 in Oncotarget
Verified
Journal Article
Open access
JWJingjing Wu
Jingjing Wu
HLHu Lei
Hu Lei
JZJinfu Zhang
Jinfu Zhang
XCXiangyun Chen
Xiangyun Chen
CTCaixia Tang
Caixia Tang
YWYINGLI WU
YINGLI WU
Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation

24 July 2014 in Journal of Proteome Research
Verified
Journal Article
Closed access
DWDonghua Wen
Donghua Wen
Zhijian XuZhijian Xu
Zhijian Xu
LXLi Xia
Li Xia
XLXinyi Liu
Xinyi Liu
YTYaoyao Tu
Yaoyao Tu
YWYINGLI WU
YINGLI WU